The Bill & Melinda Gates Foundation joins existing investor, the Wellcome Trust, each investing $20m. The funds will enable Kymab to maximise the potential of its Kymouse platform
The new business will become Horizon CombinatoRx Incorporated, a wholly owned subsidiary of Horizon. Horizon CombinatoRx will provide access to the unique cHTS platform and Chalice analytics software,
The transaction will provide Ohr Pharmaceutical with a proprietary, patent protected, sustained release technology platform under development as well as a pipeline of pre-clinical sustained release drug product
Donnatal is available in two formulations: immediate release Donnatal Tablets, and immediate release Donnatal Elixir, a fast acting liquid. For decades, Donnatal has delivered gentle relief from the
OxThera holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in eight patent families. The newly granted US patents have numbers 8,486,389 and 8,545,836.
BRF funding will expand that study to evaluate whether the "dose" of physical activity predicts the magnitude of response. "The early studies across the neuroscience community do indicate
Neos has developed an extended release (XR) amphetamine oral disintegrating tablet (ODT) and an extended release amphetamine liquid suspension both of which are expected to be filed for
Projects supported by the fund are likely to involve scientists from the two organisations working side by side, either within the MRC LMB at the Cambridge Biomedical Campus,
In the study, darapladib did not achieve the primary endpoint of a reduction of major coronary events versus placebo when added to standard of care. The overall safety
The patent is intended to protect, inter alia, the chemical structure of the active ingredient for the treatment of glaucoma. The patent is also covering the release of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.